drugset / Trial / NCT06716476

Impact of Vitamin D in Rheumatoid Arthritis

NCT06716476

Phase 4 Completed 100 enrolled University of Pristina
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this prospective, randomized, parallel-group design, double-blind, and 6-month follow-up is to evaluate the impact of 4000 IU/day vitamin D on 25-hydroxyvitamin D \[25(OH)D\] levels and inflammatory mediators in people with Rheumatoid Arthritis (RA). The main questions it aims to answer are * The level of 25(OH)D and inflammatory mediators of levels of RA differs at baseline and after 6 months of Vitamin D 4000 UI * The disease activity of AR measured by visual analogue scale (VAS) and Disease Activity Score-28 (DAS-28 score) will change in baseline and after 6 months of Vitamin D 4000 UI Researchers will compare the group of participants with Vitamin D supplementation and group of participants without D Vitamin supplementation Participants in active group will: * Take Vitamin D every day for 6 months * Visit the clinic in the first months and after 6 months for medical visits and tests.

Timeline

Start
2022-03-01
Primary completion
2023-03-31
Completion
2024-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin D Other / unclassified 4000 iu

Indications